IXICO plc (PHYOF)

0.1500 0.0000 (0.00%) As of 11:44AM EDT. Market open.

IXICO plc

Griffin Court
4th Floor 15 Long Lane
London EC1A 9PN
United Kingdom
44 20 3763 7499
https://ixico.com

Sector(s): Healthcare
Industry: Biotechnology
Full-time employees: 89

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Giulio Cerroni	CEO & Director	411.92k	N/A	1961
Mr. Grant Nash	CFO, Company Secretary & Executive Director	271.27k	N/A	N/A
Prof. Daniel Rueckert	Co-Founder & Member of Scientific Advisory Board	N/A	N/A	N/A
Prof. Derek Lionel Glendon Hill	Co-Founder and President of Regulatory Science & External Relations	486.02k	N/A	1966
Prof. David Hawkes CPhys, FInstP, FIPEM, FREng, Ph.D.	Co-Founder & Member of Scientific Advisory Board	N/A	N/A	N/A
Prof. Joseph Hajnal	Co-Founder & Member of Scientific Advisory Board	N/A	N/A	N/A
Mr. Mark Austin	Director of Technology	N/A	N/A	N/A
Dr. Robin Wolz	Chief Scientific Officer	N/A	N/A	N/A
Ms. Hannah Esfahanian	HR Manager	N/A	N/A	N/A
Dr. John Hall	Senior Vice President of Business Development	N/A	N/A	1979

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

IXICO plc provides data analytics services to the biopharmaceutical industry in the United Kingdom, Switzerland, the Netherlands, Ireland, rest of Europe, and the United States. Its services include collection, analysis, management, and reporting on data generated in the course of a clinical study. The company's technologies comprise Assessa, an online digital platform for clinics; and TrialTracker, a platform that delivers imaging services designed to manage the complex imaging workflow from image upload, quality control, and reading/analysis to reporting and data transfer. In addition, the company focuses in therapeutic areas include Alzheimer's, Parkinson's, Huntington's, Multiple Sclerosis, and orphan and rare diseases. Further, the company engages in the data collection and analysis of neurological disorders. Additionally, it offers drug development analytics, imaging operation, post marketing surveillance, and consultancy services; and end-to-end services, such as trail design and consultation, project management, imaging site set-up and management, data management, reading and analysis, and regulatory pathway. IXICO plc was incorporated in 1995 and is based in London, the United Kingdom.

Corporate governance

IXICO plc’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.